Low Testosterone Clinical Trials

A listing of Low Testosterone medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 115 clinical trials
A Study of Selexipag in Participants Who Participated in a Previous Selexipag Study

The purpose of this study is to assess the long-term safety of selexipag while providing continued selexipag treatment for participants who were previously enrolled in an Actelion-sponsored study with selexipag and who derived benefit from selexipag in indications for which a positive benefit-risk has been established.

  • 0 views
  • 12 Sep, 2021
  • 15 locations
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.

beta blockers
digoxin
pulmonary arterial hypertension
hypertension
diuretics
  • 5463 views
  • 24 Sep, 2021
  • 308 locations
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH

Study ROR-PH-302, ADVANCE CAPACITY, is designed to evaluate the effects of ralinepag therapy on exercise capacity as assessed by change in peak oxygen consumption (VO2) derived from cardiopulmonary exercise testing (CPET) after 28 weeks of treatment

stress test
endothelin receptor antagonist
exercise stress test
ralinepag
diuretics
  • 0 views
  • 22 Sep, 2021
  • 32 locations
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)

The purpose of the study is to examine how Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism (IHH) affect reproductive hormones. These disorders are caused by a defect in Gonadotropin Releasing Hormone (GnRH) secretion. GnRH is a hormone released by a small gland in the brain called the hypothalamus. When GnRH …

serum testosterone
sex hormones
secondary hypogonadism
testosterone
estradiol
  • 85 views
  • 22 Aug, 2021
  • 1 location
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

function, quality of life, body composition, muscle strength, and physical activity in young cancer survivors who report fatigue and have low testosterone. Main hypothesis is that Testosterone

chronic illness
cancer
sex hormones
solid tumors
testosterone
  • 75 views
  • 20 Jun, 2021
  • 1 location
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

outcomes such as decreased length of hospital stay, complications, and mortality in patients with low testosterone levels. Studies have demonstrated that patients undergoing testosterone replacement

  • 0 views
  • 01 Mar, 2021
  • 1 location
Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

Low testosterone and diabetes mellitus are each associated with increased risk for fractures. Men with diabetes mellitus are commonly found to have low testosterone as well. Testosterone has

testosterone
testosterone level
sugars
androgen deficiency
testosterone gel
  • 77 views
  • 01 Feb, 2021
  • 1 location
Hypogonadotropic Hypogonadism in Obese Young Males

Obesity can lead to low testosterone concentrations in young men. This study will study the effects of low testosterone in those men and the result of treating them with clomiphene.

klinefelter syndrome
testosterone
secondary hypogonadism
testosterone level
clomiphene
  • 63 views
  • 13 Aug, 2021
  • 1 location
  • 0 views
  • 14 Jun, 2021
  • 3 locations
Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients

the study without changes; unless there is rationale for change on medical ground. In order to prevent the negative effects of a low testosterone level, patients in the active group will be offered to

  • 29 views
  • 29 Jan, 2021
  • 8 locations